Who Exports Gefitinib from India — 80 Suppliers Behind a $6.8M Market
India's gefitinib export market is supplied by 80 active exporters who collectively shipped $6.8M across 297 shipments. CIPLA LIMITED leads with a 56.5% market share, followed by NATCO PHARMA LIMITED and JODAS EXPOIM PRIVATE LIMITED. The top 5 suppliers together control 94.6% of total export value, reflecting a concentrated market structure.
Top Gefitinib Exporters from India — Ranked by Export Value
CIPLA LIMITED is the leading gefitinib exporter from India, holding a 56.5% share of the $6.8M market across 297 shipments from 80 exporters. The top 5 suppliers — CIPLA LIMITED, NATCO PHARMA LIMITED, JODAS EXPOIM PRIVATE LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED, KHANDELWAL LABORATORIES PRIVATE LIMITED — collectively control 94.6% of total export value, indicating a highly concentrated market. Individual shares are: CIPLA LIMITED (56.5%), NATCO PHARMA LIMITED (25.4%), JODAS EXPOIM PRIVATE LIMITED (5.8%), NAPROD LIFE SCIENCES PRIVATE LIMITED (4.8%), KHANDELWAL LABORATORIES PRIVATE LIMITED (2.1%).
Top Gefitinib Exporters from India
Ranked by export value · 80 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED TYKITICIP 250 MG TABLETS COMMERCIALGEFTICIP 250MG TABLET PACK SIZE 3 X 10SGEFITINIB 250 MG TABLETS 30'S CI NO:124292) | $3.8M | 3 | 56.5% |
| 2 | NATCO PHARMA LIMITED TYKITICIP 250 MG TABLETS COMMERCIALGEFITINIB 250 MG TABLETS 30'S CI NO:124292)GEFITINIB 250MG TABLETS 180'S | $1.7M | 6 | 25.4% |
| 3 | JODAS EXPOIM PRIVATE LIMITED GEFITINIB TABLETS 250MGGEFONIB 250MG GEFITINIB TABLETS 250MGGEFONIB 250MG GEFITINIB TABLETS 250MG 1 | $395.7K | 5 | 5.8% |
| 4 | NAPROD LIFE SCIENCES PRIVATE LIMITED GEFONIB 250MG GEFITINIB TABLETS 250MGGEFONIB 250MG GEFITINIB TABLETS 250MG 1GAFVEX 250 | $327.9K | 2 | 4.8% |
| 5 | KHANDELWAL LABORATORIES PRIVATE LIMITED GABISOF 250MG (GABISOF 250MGZEFTIGLO (GEFITINIB TABLETS 250 | $139.8K | 1 | 2.1% |
| 6 | PROSPERA LIFE SCIENCES PRIVATE LIMITED | $47.4K | 4 | 0.7% |
| 7 | UNITED BIOTECH PRIVATE LIMITED | $45.6K | 4 | 0.7% |
| 8 | VEXXA LIFESCIENCES PVT. LTD. GEFONIB 250MG GEFITINIB TABLETS 250MGGEFONIB 250MG GEFITINIB TABLETS 250MG 1GAFVEX 250 | $45.6K | 1 | 0.7% |
| 9 | ASPIDA LIFE SCIENCES PRIVATE LIMITED GEFITINIB TABLETS I.P. 1*30 STRIP BATCHGEFONIB 250 MG TAB GEFITINIB TABLETS IP | $39.0K | 3 | 0.6% |
| 10 | HEET HEALTHCARE PRIVATE LIMITED GEFONIB 250MG GEFITINIB TABLETS 250MGGEFONIB 250MG GEFITINIB TABLETS 250MG 1GAFVEX 250 | $16.3K | 3 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Gefitinib exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| CIPLA LIMITED | Approved | Yes | Yes | Multiple | Cipla has received multiple FDA approvals for various medications, including Nil |
| NATCO PHARMA LIMITED | Approved | Yes | Yes | Multiple | Natco received FDA approval for Lenalidomide Capsules in May 2021. |
| JODAS EXPOIM PRIVATE LIMITED | Not Listed | Yes | No | Not verified | Jodas Expoim is listed as a WHO-GMP certified manufacturer. |
| NAPROD LIFE SCIENCES PRIVATE LIMITED | Not Listed | Yes | No | Not verified | Naprod Life Sciences holds WHO-GMP certification. |
| KHANDELWAL LABORATORIES PRIVATE LIMITED | Not Listed | Yes | No | Not verified | Khandelwal Laboratories is WHO-GMP certified. |
| UNITED BIOTECH PRIVATE LIMITED | Not Listed | Yes | No | Not verified | United Biotech is listed among WHO-GMP certified manufacturers. |
| VEXXA LIFESCIENCES PVT. LTD. | Not Listed | Yes | No | Not verified | Vexxa Lifesciences holds WHO-GMP certification. |
| ASPIDA LIFE SCIENCES PRIVATE LIMITED | Not Listed | Yes | No | Not verified | Aspida Life Sciences is WHO-GMP certified. |
| HEET HEALTHCARE PRIVATE LIMITED | Not Listed | Yes | No | Not verified | Heet Healthcare holds WHO-GMP certification. |
TransData Nexus reviewed the regulatory standing of 9 leading Gefitinib exporters from India. 2 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 2 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Gefitinib sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for pharmaceutical manufacturing. The city hosts Genome Valley, a premier life sciences cluster that includes over 200 life sciences companies and 269 USFDA-approved facilities. This concentration of infrastructure and expertise makes Hyderabad a critical center for the production of active pharmaceutical ingredients (APIs) and bulk drugs, including those used in the formulation of Gefitinib.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical industry, particularly in the formulation segment. Gujarat houses 13 pharmaceutical clusters, with Ahmedabad and Vadodara being prominent centers. These cities are home to major companies like Alembic Pharmaceuticals and Torrent Pharmaceuticals, which specialize in the development and manufacturing of generic formulations. The region's well-established infrastructure and skilled workforce contribute to its status as a formulations hub.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a crucial export gateway for pharmaceutical products. Maharashtra leads India with 40 pharmaceutical clusters, facilitating significant export activities. Mumbai, as the financial capital, provides logistical advantages, while Thane and Raigad host numerous manufacturing units. Companies like Cipla Limited, headquartered in Mumbai, leverage this strategic location to efficiently distribute products like Gefitinib to international markets.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives. The area hosts seven pharmaceutical clusters, attracting numerous companies seeking cost-effective production solutions. This region's growth underscores the impact of policy-driven incentives on the pharmaceutical industry's geographic distribution.
5Sourcing Recommendations
- Diversify Supplier Base: While CIPLA LIMITED and NATCO PHARMA LIMITED dominate Gefitinib exports, consider engaging with other manufacturers in different clusters to mitigate supply chain risks.
- Leverage Regional Specializations: Utilize Hyderabad for bulk drug procurement, Ahmedabad-Vadodara for formulations, and Mumbai-Thane-Raigad for export logistics to optimize the supply chain.
- Monitor Regulatory Compliance: Ensure that suppliers across these clusters adhere to international quality standards, given the high concentration of USFDA-approved facilities in regions like Hyderabad.
- Assess Infrastructure and Incentives: Evaluate the infrastructure capabilities and fiscal incentives of regions like Baddi-Nalagarh to identify cost-effective sourcing opportunities.
By strategically aligning sourcing activities with the strengths of India's pharmaceutical clusters, companies can enhance supply chain resilience and efficiency in the procurement of Gefitinib.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Gefitinib exporters from India
Cipla Limited — Cipla secures bid to supply generic drugs in China
In November 2025, Cipla Limited was among the Indian pharmaceutical companies selected to supply key generic drugs, including Dapagliflozin, in China. This selection was part of a bidding process conducted by the Chinese health ministry for pharmaceutical procurement. - IMPACT: This collaboration may enhance Cipla's market presence in China, potentially increasing demand for its generic drugs, including Gefitinib.
Impact: This collaboration may enhance Cipla's market presence in China, potentially increasing demand for its generic drugs, including Gefitinib.
Natco Pharma Limited — Natco Pharma wins bid to supply generic drugs in China
In November 2025, Natco Pharma Limited was selected to supply key generic drugs, including Dapagliflozin, in China. This selection was part of a bidding process conducted by the Chinese health ministry for pharmaceutical procurement. - IMPACT: This collaboration may expand Natco Pharma's footprint in the Chinese market, potentially boosting exports of its generic drugs, including Gefitinib.
Impact: This collaboration may expand Natco Pharma's footprint in the Chinese market, potentially boosting exports of its generic drugs, including Gefitinib.
Cipla Limited — Cipla's subsidiary, Cipla Dibcare, dissolved
In January 2024, Cipla Limited reported the dissolution of its subsidiary, Cipla Dibcare (Pty) Limited, effective June 26, 2024. This was disclosed in the company's financial statements. - IMPACT: The dissolution of this subsidiary is unlikely to have a direct impact on Cipla's Gefitinib exports.
Impact: The dissolution of this subsidiary is unlikely to have a direct impact on Cipla's Gefitinib exports.
Common Questions — Gefitinib Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which gefitinib supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, CIPLA LIMITED leads with 21 recorded shipments worth $3.8M. NATCO PHARMA LIMITED (10 shipments) and JODAS EXPOIM PRIVATE LIMITED (11 shipments) are also established high-volume exporters.
Q How many gefitinib manufacturers are there in India?
India has 80 active gefitinib exporters with a combined export market of $6.8M across 297 shipments to 47 countries. The top 5 suppliers hold 94.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for gefitinib from India?
Average FOB unit price: $27.71 per unit, ranging from $0.10 to $386.34. Average shipment value: $22.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 80 verified Indian exporters of Gefitinib ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 297 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 47 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
297 Verified Shipments
80 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists